Canadian Update: Lasmiditan (Reyvow™ in the US) will not be coming to Canada
An announcement was recently made that lasmiditan, a new medication for the treatment of migraine attacks, developed by Eli Lilly, will not be available in Canada. This news was disappointing as more options are always welcome and needed for people with migraine. Lasmiditan acts on…
gammaCore Sapphire Device for Non-Invasive Vagal Nerve Stimulation and Migraine
What is it? The gammaCore SapphireTM (nVNS) is a hand-held device that the patient uses to stimulate the vagus nerve in the neck. The vagus nerve is an important highway of communication between the body and the brain and plays an important role in regulating…
Shruti’s Story
“I interviewed Shruti a few months ago and she has written the following to share her story:” I don’t remember life without pain, or migraine. I was 12 or 13 when I was first diagnosed. It was after years of trying to articulate the pain….
Migraine Talks Podcast
Dear Friends, Migraine Canada™ is proud to present its latest media production, “Migraine Talks” with Dr. Elizabeth Leroux. Migraine Talks is a series of 12 episodes which you can listen to on MigraineCanada.org, on Apple Podcast, on Google Podcast, and on Spotify! While exploring the basics…
Canadian Clusterbusters : time to unite
The worst pain of all Attacks of excruciating pain around the eye and temple, just on this one side. A hot poker pushed inside your face. Your eye tears, your nose runs. For an hour or two, you are in hell. The attack is brutal,…
Suvexx™ – a new combination product for acute migraine treatment
What is Suvexx? Suvexx is a combination of two commonly used acute migraine medications in a single tablet: sumatriptan 85 mg and naproxen sodium 500 mg. This product has been available in the U.S. for many years under the brand name Treximet. Combining a triptan…
An Introduction to Project: Your Voice
One of Migraine Canada’s goals is to provide support to those with migraine by sharing information and combating stigma. One of the ways to accomplish this goal is by amplifying the voices of the migraine community to provide insight into what living with migraine is truly like. “Your Voice”, led by…
Tips for Athletes with Migraine
Whether you’re a professional athlete or play sports casually, migraines can affect your ability to participate in athletics. Being aware of how to manage your symptoms and prevent migraine attacks are key to limiting the effect of migraines on your athletic commitments. Here are a…
Travelling tips when you live with migraine
Are you in the midst of planning a trip and concerned about how migraines will affect your travels? We’ve put together this list of commonly asked questions and answers to help you. Is travelling a bad idea if I get migraines? The answer to this…
A case demonstrating how a combination of Botox and erenumab can improve person’s quality of life: research from a Quebec team
Both Botox and CGRP antibodies can be effective for Chronic Migraine. Still, 50 to 50% of patients do not get this response for Botox or CGRP antibodies. What if a combination was used? A team from Quebec City reports on a 52 years-old woman suffering…
Can travelling to a higher altitude trigger migraine attacks?
For some people with migraine, the answer seems to be yes. In people who climbed a mountain in Colorado (4,300 metres high), people with a history of migraine were 2.5 times more likely to develop a headache than those who did not have migraine. They were…
Combining Botox and a CGRP antibody: should it be covered by insurance companies?
It has come to the attention of Migraine Canada™ that many insurance companies are now refusing to cover the combination of Botox and a CGRP monoclonal antibody (BTX + CGRP MAB). Currently available CGRP monoclonal antibodies are erenumab (Aimovig) and galcanezumab (Emgality). Fremanezumab (Ajovy) is…
